GTR Home > Tests > Search results - AP3B1[gene]

Apply filters

Showing tests for all 1504 conditions

Compare labs

Your search term can be found in tests with a total of 1504 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for 8546[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 24 tests for 1504 conditions in 13 labs

CBleeding Disorder NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (31)
Total targets (34)

CPlatelet Function Disorder NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (14)
Total targets (17)

CPulmonary Fibrosis - Hermansky-Pudlak Panel (20 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (19)
Total targets (20)

CPulmoGene Panel (57 genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (55)
Total targets (57)

CHermansky-Pudlak Syndrome Panel (9 Genes)

Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (9)
Total targets (9)

CHermansky-Pudlak Syndrome Type 2 (HPS2) via the AP3B1 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CHermansky-Pudlak Syndrome (HPS) Sanger Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (8)
Total targets (8)

CAP3B1. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CHLH/immunedisregulation panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (9)
Total targets (9)

CIntellectual Disability NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (753)
Total targets (392)

CLung Disease NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (86)
Total targets (51)

CHermansky Pudlak Syndrome NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (11)
Total targets (9)

CHermansky-Pudlak Syndrome 2

Lab: MedGene Bratislava, Bratislava, Slovakia
Test targets
Methods
  • C Sequence analysis of the entire coding region

CHermansky-Pudlak Syndrome 2

Lab: Praxis fuer Humangenetik Wien Vienna, Wien, Austria
Test targets
Methods
  • C Sequence analysis of the entire coding region

CTest for Hermansky-Pudlak Syndrome 2

Lab: MedGene Medgene Bratislava, Slovakia
Test targets
Methods
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 24 tests for 1504 conditions in 13 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk